Pharmadax Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 397.15 million compared to TWD 287.2 million a year ago. Net loss was TWD 310.51 million compared to TWD 314.93 million a year ago. Basic loss per share from continuing operations was TWD 4.49 compared to TWD 5.02 a year ago. Diluted loss per share from continuing operations was TWD 4.49 compared to TWD 5.02 a year ago.